Evidence map›Paper›PMID 38832781›Full record

ArticlemSphere2024

Multicenter retrospective genomic characterization of carbapenemase-producing

An Xu, Min Li, Yaping Hang, Lingbing Zeng, Xuefei Zhang, Yiyi Hu, Qinglan Guo, Minggui Wang

Abstract readMulticenter Study
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Convergent evolution of ST2 and ST164 mediates dissemination of the blaAnnals of clinical microbiology and antimicrobials · 2026
    Article
  3. Article
  4. Genomic characterization of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  5. Isolation and whole-genome characterization of multidrug-resistant Acinetobacter baumannii from Indian retail meat: unveiling high-risk clones and zoonotic transmission threats via comparative genomics.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  6. Prevalence and antimicrobial resistance ofOne health (Amsterdam, Netherlands) · 2025
    Article
  7. Article
  8. Article
  9. Whole-genome sequencing ofMicrobial genomics · 2025
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

An XuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.ORCID 0009-0001-2914-5639
Min LiDepartment of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Yaping HangDepartment of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Lingbing ZengDepartment of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Xuefei ZhangInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Yiyi HuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Qinglan Guo *Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.ORCID 0000-0003-2490-1201
Minggui Wang *Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.ORCID 0000-0001-7682-5859

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to characterize carbapenem-resistant IMPORTANCE: Carbapenem-resistant

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesMicrobial Sensitivity TestsMolecular EpidemiologyMultilocus Sequence TypingWhole Genome SequencingAdultAgedCarbapenemsElectrophoresis, Gel, Pulsed-FieldFemaleGenome, BacterialGenomicsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsblaNDM-1blaOXA-23Carbapenem-resistant Acinetobacter baumanniiIC11IC2

Identifiers

PMID38832781
PMCPMC11332331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.